Table 1 Characteristics and clinical medication of the patients.

From: Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome

  Normal controls
(n = 41)
PCOS cases
(n = 38)
P-value
Mean ± SD Mean ± SD
Age 30.6 ± 3.8 30.3 ± 4.0 0.734 a
BMI (kg/m2) 22.8 ± 3.4 23.4 ± 3.7 0.456 a
Days of Gn application 11.7 ± 2.0 11.8 ± 3.0 0.805 b
Total dose of Gn (IU) 2563.1 ± 946.9 2338.2 ± 824.1 0.263 a
E2 level on hCG day (pmol/l) 9488.2 ± 4100.7 9873.2 ± 5977.4 0.941 b
P level on hCG day (nmol/l) 2.8 ± 1.3 2.4 ± 1.4 0.192 a
  1. aStudent’s t-test.
  2. bMann-Whitney test (Variance is not equal, nonparametric test).
  3. Gn: gonadotropin; E2: estradiol; P: progesterone; hCG: human chorionic gonadotropin.